Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Specialties
Publications
Articles from Nancy Dvorin:
Read all from this author
Perspective & Commentary

Digital Edition: MedTech Strategist April 2026

  • 2026-04-01 00:00:00.0
  • Nancy Dvorin
  • MedTech Strategist

The US launch of the Liberant ultrasonic controlled thrombectomy system was the first milestone in Medtronic’s move into the fast-growing peripheral market. Emerging innovators accelerate the treatment of tricuspid valve disease, which has lagged other CV interventions. Median Technologies gains FDA clearance for its eyonis LCS AI-based lung cancer screening device and from Market Pathways, Boston Scientific's quest for reimbursement of its Intracept chronic low back pain technology.

Read Article